Long non‐coding <scp> RNA <i>H19</i> </scp> as a biomarker for hepatocellular carcinoma-Reference-Cited by-同舟云学术

Long non‐coding RNA H19 as a biomarker for hepatocellular carcinoma

Published:2022-03-12 Issue:6 Volume:42 Page:1410-1422
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Rojas Ángela¹²,Gil‐Gómez Antonio¹²,de la Cruz‐Ojeda Patricia³,Muñoz‐Hernández Rocío¹²,Sánchez‐Torrijos Yolanda¹⁴,Gallego‐Durán Rocío¹²^ORCID,Millán Raquel¹,Rico María Carmen¹,Montero‐Vallejo Rocío¹,Gato‐Zambrano Sheila¹,Maya‐Miles Douglas¹,Ferrer M. Teresa⁴,Muntané Jordi²³⁵^ORCID,Robles‐Frías María José⁶,Ampuero Javier¹²⁴^ORCID,Padillo Francisco J.²³⁷,Romero‐Gómez Manuel¹²⁴^ORCID

Affiliation:

1. Seliver Group, Institute of Biomedicine of Seville/ /Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla Sevilla Spain

2. Hepatic and Digestive Diseases Networking Biomedical Research Centre (CIBERehd) Madrid Spain

3. Institute of Biomedicine of Seville/ /Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla Sevilla Spain

4. Digestive Diseases Unit Hospital Universitario Virgen del Rocío Sevilla Spain

5. Department of Medical Physiology and Biophysics University of Seville Seville Spain

6. Pathology Department Hospital Universitario Virgen del Rocío Seville Spain

7. General Surgery Department Hospital Universitario Virgen del Rocío Seville Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15230

Reference39 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Epidemiology and Management of Hepatocellular Carcinoma

3. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

4. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma

5. Treatment of Hepatocellular Carcinoma in the Precision Medicine Era: From Treatment Stage Migration to Therapeutic Hierarchy

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and validation of a five-necroptosis-related lncRNAs signature for prognostic prediction in hepatocellular carcinoma;Heliyon;2024-09

2. A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma;Translational Oncology;2024-07

3. Current updates on the molecular and genetic signals as diagnostic and therapeutic targets for hepatitis B virus-associated hepatic malignancy;Heliyon;2024-07

4. Association of long noncoding RNA H19 rs2839698 C/T with hepatitis B virus infection and hepatocellular carcinoma risk;Journal of Biochemical and Molecular Toxicology;2024-03-13

5. Long Noncoding RNAs MALAT1 and HOTTIP Act as Serum Biomarkers for Hepatocellular Carcinoma;Cancer Control;2024-01